Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancy

Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

166 public trials 63 recruiting studies

Hematologic Malignancy trial results

Conditions
AML (Acute Myelogenous Leukemia), B-cell Lymphoma, Chronic Disease, +33 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus Dresden, Germany
  • Universitätsklinikum Marburg Marburg, Germany
  • Klinikum der Universität (LMU) Muenchen Munich, Germany
Enrolling by Invitation

Long-Term Follow-up Study

NCT05332054

Conditions
B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
View all 31 locations
Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +4 more
Locations
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Stanford Stanford, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
View all 22 locations